{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:08:21Z","timestamp":1791504501733,"version":"4.3.4"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In this study, we aimed to determine an ordinary\/empiric\/standard phototherapy treatment protocol for duration without controlling total serum bilirubin (TSB) levels after initiating phototherapy in early-term and full-term jaundiced newborns who had no hyperbilirubinemia neurotoxicity risk factors. We compared two groups, each receiving either 24\u2009h (Group I) or 18\u2009h (Group II) of continuous phototherapy in terms of demographic characteristics and efficacy (rate of decrease in TSB levels with phototherapy). No control TSB measurements were performed in the study groups until the end of phototherapy for the predetermined durations. Declines in TSB after phototherapy were significantly greater in Group I than in Group II, both in terms of mg\/dl (11.81\u2009\u00b1\u20092.93\u2009mg\/dl vs. 10.75\u2009\u00b1\u20092.48\u2009mg\/dl, P\u2009=\u2009.0008) and percentage (56.71\u2009\u00b1\u20099.06% vs. 52.86\u2009\u00b1\u20098.37%, P\u2009=\u2009.0002). However, the rate of TSB reduction after phototherapy in mg\/dl\/h (0.59\u2009\u00b1\u20090.13\u2009mg\/dl\/h vs. 0.49\u2009\u00b1\u20090.12\u2009mg\/dl\/h, P\u2009=\u2009&amp;lt;.0001) and percentage per hour (2.93\u2009\u00b1\u20090.37% vs. 2.36\u2009\u00b1\u20090.46%, P\u2009=\u2009&amp;lt;.0001) were significantly higher in Group II than in Group I. This indicates an inverse time-response relationship between the duration of phototherapy and the response rate in the study groups. Although the 24-h phototherapy course showed greater efficacy concerning the primary bilirubin outcome measures (decline in TSB in mg\/dl and %), the 18-h course of phototherapy treatment provided better hourly outcomes and reached its saturation point around the 18th hour. Therefore, an 18-h phototherapy without TSB monitoring until the end of the phototherapy should be considered for jaundiced newborns lacking neurotoxicity risk factors.<\/jats:p>","DOI":"10.1093\/tropej\/fmae037","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T06:12:24Z","timestamp":1728627144000},"source":"Crossref","is-referenced-by-count":1,"title":["Duration of a standard phototherapy course in jaundiced newborns with no neurotoxicity risk"],"prefix":"10.1093","volume":"70","author":[{"given":"Serdar \u00dcmit","family":"Sarici","sequence":"first","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, Ufuk University Faculty of Medicine , Mevlana Blv. No: 86-88 , Ankara 06520,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00fcbra","family":"Arslan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ufuk University Faculty of Medicine , Ankara 06520,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altay","family":"Babacan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ufuk University Faculty of Medicine , Ankara 06520,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demet","family":"Soylu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ufuk University Faculty of Medicine , Ankara 06520,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayca T\u00f6rel","family":"Erg\u00fcr","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ufuk University Faculty of Medicine , Ankara 06520,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhittin Abdulkadir","family":"Serdar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Clinical Biochemistry, Ac\u0131badem University Faculty of Medicine , Ankara 06460,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Sarici","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, Health Sciences University, Kecioren Education and Research Hospital , Ankara 06290,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"2024101106121666400_fmae037-B1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1542\/peds.113.4.775","article-title":"Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns","volume":"113","author":"Sarici","year":"2004","journal-title":"Pediatrics"},{"key":"2024101106121666400_fmae037-B2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.114.1.297","article-title":"Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation","volume":"114","author":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia","year":"2004","journal-title":"Pediatrics"},{"key":"2024101106121666400_fmae037-B3","doi-asserted-by":"crossref","first-page":"2022058859","DOI":"10.1542\/peds.2022-058859","article-title":"Clinical Practice Guideline Revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation","volume":"150","author":"Kemper","year":"2022","journal-title":"Pediatrics"},{"key":"2024101106121666400_fmae037-B4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mrgentox.2007.06.013","article-title":"Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates","volume":"654","author":"Tatli","year":"2008","journal-title":"Mutat Res"},{"key":"2024101106121666400_fmae037-B5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/jp.2015.166","article-title":"Jaundice, phototherapy and DNA damage in full-term neonates","volume":"36","author":"Ramy","year":"2016","journal-title":"J Perinatol"},{"key":"2024101106121666400_fmae037-B6","doi-asserted-by":"crossref","first-page":"e20180648","DOI":"10.1542\/peds.2018-0648","article-title":"Childhood seizures after phototherapy","volume":"142","author":"Newman","year":"2018","journal-title":"Pediatrics"},{"key":"2024101106121666400_fmae037-B7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.eplepsyres.2016.05.004","article-title":"Neonatal hyperbilirubinemia and the risk of febrile seizures and childhood epilepsy","volume":"124","author":"Maimburg","year":"2016","journal-title":"Epilepsy Res"},{"key":"2024101106121666400_fmae037-B8","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1203\/00006450-198208000-00018","article-title":"The pattern of bilirubin response to phototherapy for neonatal hyperbilirubinaemia","volume":"16","author":"Tan","year":"1982","journal-title":"Pediatr Res"},{"key":"2024101106121666400_fmae037-B9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/01480545.2011.653491","article-title":"Phototherapy causes a transient DNA damage in jaundiced newborns","volume":"36","author":"Kahveci","year":"2013","journal-title":"Drug Chem Toxicol"},{"key":"2024101106121666400_fmae037-B10","doi-asserted-by":"crossref","first-page":"105465","DOI":"10.1016\/j.earlhumdev.2021.105465","article-title":"Intensive phototherapy and oxidant-antioxidant status in infants with jaundice","volume":"161","author":"Iskander","year":"2021","journal-title":"Early Hum Dev"},{"key":"2024101106121666400_fmae037-B11","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1542\/hpeds.2021-006295","article-title":"The effect of readmission for phototherapy on early breast milk feeding","volume":"12","author":"Digitale","year":"2022","journal-title":"Hosp Pediatr"},{"key":"2024101106121666400_fmae037-B12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0022-3476(77)80714-2","article-title":"The nature of the dose-response relationship of phototherapy for neonatal hyperbilirubinemia","volume":"90","author":"Tan","year":"1977","journal-title":"J Pediatr"},{"key":"2024101106121666400_fmae037-B13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.clp.2016.01.004","article-title":"A pharmacologic view of phototherapy","volume":"43","author":"Lamola","year":"2016","journal-title":"Clin Perinatol"},{"key":"2024101106121666400_fmae037-B14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1651-2227.2008.01015.x","article-title":"When should phototherapy be stopped? A pilot study comparing two targets of serum bilirubin concentration","volume":"98","author":"Barak","year":"2009","journal-title":"Acta Paediatr"},{"key":"2024101106121666400_fmae037-B15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4103\/ijmr.IJMR_2156_18","article-title":"Comparison of efficacy, safety & satisfaction of intermittent versus continuous phototherapy in hyperbilirubinaemic newborns \u226535 week gestation: a randomized controlled trial","volume":"153","author":"Gottimukkala","year":"2021","journal-title":"Indian J Med Res"},{"key":"2024101106121666400_fmae037-B16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/jan.14535","article-title":"Efficacy of \u0131ntermittent phototherapy versus continuous phototherapy for treatment of neonatal hyperbilirubinaemia: a systematic review and meta-analysis","volume":"77","author":"Chu","year":"2021","journal-title":"J Adv Nurs"},{"key":"2024101106121666400_fmae037-B17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00431-014-2373-8","article-title":"Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age: a randomized controlled trial","volume":"174","author":"Sachdeva","year":"2015","journal-title":"Eur J Pediatr"}],"container-title":["Journal of Tropical Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/tropej\/article-pdf\/70\/6\/fmae037\/59716644\/fmae037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/tropej\/article-pdf\/70\/6\/fmae037\/59716644\/fmae037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T06:12:29Z","timestamp":1728627149000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/tropej\/article\/doi\/10.1093\/tropej\/fmae037\/7818158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,10,4]]}},"URL":"https:\/\/doi.org\/10.1093\/tropej\/fmae037","relation":{},"ISSN":["1465-3664"],"issn-type":[{"value":"1465-3664","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,10,4]]},"article-number":"fmae037"}}